foxo4-dri senolytic peptide animal study

foxo4-dri senolytic peptide animal study FOXO4-DRI: Human Trial Status, Cancer Research & Data FOX04-DRI - Apollo Peptide Sciences

Name: foxo4-dri senolytic peptide animal study FOXO4-DRI: Human Trial Status, Cancer Research & Data FOX04-DRI - Apollo Peptide Sciences
Brand: trustt.digital
SKU: 62496469346
Price: 21.00 USD
Availability: InStock
Rating: 4.4581 (21 reviews)

FOX04 DRI Apollo Peptide Sciences Development of a novel senolytic by precise disruption of FOXO4 p53 complex eBioMedicine FOXO4 an overview ScienceDirect Topics Peptide inhibitors targeting FOXO4 p53 interactions and inducing senescent cancer cell specific apoptosis bioRxiv

SKU: 62496469346 · From trustt.digital

4.5

USD21.00 USD67.00

Pay in 4 interest-free payments of $5.25 Learn more

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Aug 3 - Aug 8

Description

642 Together, ACMSD and NNMT provide novel targets for modulating NAD + homeostasis, which will be of great importance to determine whether ACMSD and NNMT inhibitors can increase NAD + levels and achieve therapeutic effects